Correction to ‘Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease’

R. M. Pipitone, F. Malvestiti, G. Pennisi, et al., “ Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease,” Liver International 43, no. 8 (2023): 1761–1771, https://doi.org/10.1111/liv.15586. The Funding section of the originally published article contained an incomplete project reference. The original funding statement has been replaced with the following text: ‘Funded by the European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS. Project Cod. PNRR-MAD-2022-12375656, title “RATIONAL: Risk stratification Of Nonalcoholic fatty Liver” – CUP: I75E22000540006’. We apologize for this error.

Publication Details

Journal
Liver International
Published
2026-07-01
DOI
https://doi.org/10.1111/liv.70768
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction to ‘Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease’

Liver International
Liver Disease Diagnosis and Treatment
article

Correction to ‘Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease’

article en

Abstract

R. M. Pipitone, F. Malvestiti, G. Pennisi, et al., “ Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease,” Liver International 43, no. 8 (2023): 1761–1771, https://doi.org/10.1111/liv.15586. The Funding section of the originally published article contained an incomplete project reference. The original funding statement has been replaced with the following text: ‘Funded by the European Union - Next Generation EU - NRRP M6C2 - Investment 2.1 Enhancement and strengthening of biomedical research in the NHS. Project Cod. PNRR-MAD-2022-12375656, title “RATIONAL: Risk stratification Of Nonalcoholic fatty Liver” – CUP: I75E22000540006’. We apologize for this error.

Liver InternationalVol. 46(8)
Partnerships for the goals
Openalex Percentile: Top 7%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Correction to ‘Programmed Cell Death 1 Genetic Variant and Liver Damage in Nonalcoholic Fatty Liver Disease’ · Liver International (2026) | TGRS Research Map | TGRS